News Headlines Article

FDA approves generic cholesterol-lowering Lipitor
USA Today

India’s largest maker of generic drugs won approval late Wednesday to sell a generic version of cholesterol blockbuster Lipitor. The world’s top-selling drug ever lost U.S. patent protection earlier in the day. The U.S. Food and Drug Administration said it granted Ranbaxy Laboratories Ltd. approval to sell a generic verson of Pfizer Inc.’s Lipitor, called atorvastatin calcium. The last-minute decision ended widespread speculation over the outcome of a delay caused by long-standing manufacturing issues at some Ranbaxy factories.

Commands